DOCSLIB.ORG

Null Mutations in Human and Mouse Orthologs Frequently Result in Different Phenotypes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Null Mutations in Human and Mouse Orthologs Frequently Result in Different Phenotypes Null mutations in human and mouse orthologs frequently result in different phenotypes Ben-Yang Liao and Jianzhi Zhang* Department of Ecology and Evolutionary Biology, University of Michigan, Ann Arbor, MI 48109 Edited by David J. Lipman, National Institutes of Health, Bethesda, MD, and approved March 10, 2008 (received for review January 14, 2008) One-to-one orthologous genes of relatively closely related species biomedical research, the international genetics community re- are widely assumed to have similar functions and cause similar cently initiated the Knockout Mouse Project (KOMP) to indi- phenotypes when deleted from the genome. Although this as- vidually knock out every gene in the mouse genome and acquire sumption is the foundation of comparative genomics and the basis phenotypic data (16). Our analysis will be valuable in guiding the for the use of model organisms to study human biology and proper use of the KOMP data. disease, its validity is known only from anecdotes rather than from In the present study, we focus on one of the most dramatic systematic examination. Comparing documented phenotypes of types of change in a gene’s phenotypic effect, namely, a change null mutations in humans and mice, we find that >20% of human in gene essentiality. A gene is said to be essential to an organism essential genes have nonessential mouse orthologs. These changes if the loss of its function renders the fitness of the organism zero; of gene essentiality appear to be associated with adaptive evolu- otherwise, the gene is said to be nonessential. We show that tion at the protein-sequence, but not gene-expression, level. Pro- Ͼ20% of human essential genes have nonessential mouse or- teins localized to the vacuole, a cellular compartment for waste thologs and elucidate the mechanisms underlying the changes of management, are highly enriched among essentiality-changing gene essentiality in evolution. genes. It is probable that the evolution of the prolonged life history in humans required enhanced waste management for proper Results and Discussion cellular function until the time of reproduction, which rendered Many Human Essential Genes Have Nonessential Mouse Orthologs. these vacuole proteins essential and generated selective pressures From Online Mendelian Inheritance in Man (OMIM) (19), we for their improvement. If our gene sample represents the entire identified 1,716 human genes with clear gene–disease associations, genome, our results would mean frequent changes of phenotypic in which 1,450 genes have unambiguous one-to-one orthologs in the effects of one-to-one orthologous genes even between relatively mouse genome (see Methods). This set contains 756 human genes closely related species, a possibility that should be considered in whose mouse orthologs have been experimentally deleted with the comparative genomic studies and in making cross-species infer- resulting phenotypes cataloged in the database of Mouse Genome ences of gene function and phenotypic effect. Informatics (MGI). For the 594 human genes associated with mild diseases, we cannot infer gene essentiality, because mild diseases evolution ͉ mammals ͉ gene essentiality ͉ vacuole may be due to mild mutations in essential genes or null mutations in nonessential genes. From the remaining 162 potentially essential hen a species diverges into two separate species, the genes, we removed 24 immunity-related genes, because the essen- Wdivergent copies of a single gene in the resulting species tiality of their mouse orthologs may not have been adequately are said to be orthologous (1, 2). Although genome-wide pat- assessed in lab. We further removed 18 genes for which there is no terns of conservation between orthologous genes have been evidence that the human disease is due to null mutations. We thus extensively studied at the DNA and protein-sequence levels focused on the remaining 120 human genes with clinical features of (3–5) and have started to be investigated at the gene-expression death before puberty (20) or infertility when null mutations occur, level (6–9), little is known about the evolutionary conservation and considered them to be essential in human [supporting infor- at the levels of gene function and phenotypic effect on gene mation (SI) Dataset S1]. We determined the essentiality of the deletion. This lack of knowledge is in part due to the widely held mouse orthologs of these human genes, based on MGI and relevant presumption that orthologous genes from different species are literature. Specifically, a mouse gene is considered essential if the similar in function and phenotypic effect (2), which probably knockout mice cannot survive to reproductive age (50 days) or are originated from a few reports that orthologous genes from infertile. distantly related species can be swapped without causing appar- To our surprise, 27 (22.5%) of the 120 mouse orthologs of human ent phenotypic defects (10–13). Because this presumption is essential genes are nonessential (Table 1 and Dataset S1). Further- fundamental to comparative genomics (5, 14) and is the basis for more, except for reduced survival or fecundity for Mthfr, Smpd1 using model organisms such as mice to study human biology and Hexb, and Neu1-knockout mice, the other 23 knockout mouse disease (15, 16), it deserves a systematic verification. strains (19.2%) are able to breed as successfully as the wild type at Two model organisms, the bacterium Escherichia coli (17) and least up to the age of 6 months (Table 1). For convenience, we term the yeast Saccharomyces cerevisiae (18), have been subject to these 27 human-essential–mouse-nonessential orthologs as HeMn genome-wide gene-deletion experiments with available infor- orthologs and the other 93 human-essential–mouse-essential or- mation on the fitness of each gene-deletion strain and thus could be compared in terms of the phenotypes of orthologous deletions Author contributions: B.-Y.L. and J.Z. designed research; B.-Y.L. performed research; B.-Y.L. at the genomic scale. However, these two organisms belong to and J.Z. analyzed data; and B.-Y.L. and J.Z. wrote the paper. prokaryotes and eukaryotes, respectively, and are so different The authors declare no conflict of interest. even in basic cellular processes that the comparison is neither This article is a PNAS Direct Submission. feasible nor meaningful. We thus choose to compare human *To whom correspondence should be addressed at: Department of Ecology and Evolution- (Homo sapiens) and mouse (Mus musculus), which are both ary Biology, University of Michigan, 1075 Natural Science Building, 830 North University placental mammals and have overall similar biology. Our com- Avenue, Ann Arbor, MI 48109. E-mail: [email protected]. parison also has practical value because of the common use of This article contains supporting information online at www.pnas.org/cgi/content/full/ EVOLUTION mouse as a model organism for studying human biology and 0800387105/DCSupplemental. disease. In fact, to facilitate the use of mouse models in human © 2008 by The National Academy of Sciences of the USA www.pnas.org͞cgi͞doi͞10.1073͞pnas.0800387105 PNAS ͉ May 13, 2008 ͉ vol. 105 ͉ no. 19 ͉ 6987–6992 Downloaded by guest on September 27, 2021 Table 1. One-to-one orthologous genes that are essential in human but nonessential in mouse Human gene name Human disease name Mouse gene knockout phenotypes Arylsulfatase A (ARSA)* Metachromatic leukodystrophy† Normal fertility and litter size; impaired balance and spatial learning ability; sulfatide accumulation in the white matter of the brain; reduced myelin sheath thickness in the corpus callosum and optic nerves; a low frequency head tremor develops after 2 years of age. ␣-Mannosidase, class 2B, member 1 (MAN2B1) Mannosidosis, ␣-, types I and II† Normal development and fertility; no elevated mortality; mild form of human ␣-mannosidosis Dystrophia myotonica protein kinase (DMPK)* Myotonic dystrophy-1† Normal fertility and litter size; abnormal sodium channel gating in cardiac myocytes; cardiac conduction defects; late-onset progressive skeletal myopathy; abnormal muscle intracellular calcium levels Lysosomal acid lipase (LIPA) Wolman disease; cholesteryl ester Normal development and fertility; accumulation of storage disease† triglycerides and cholesteryl esters occurs in several organs Axonemal heavy chain dynein type 11 (DNAH11) Primary ciliary dyskinesia; Normal fertility; abnormal left–right axis patterning Kartagener syndrome‡ Sialyltransferase 9 (ST3GAL5) Amish infantile epilepsy syndrome† Normal viability and fertility; hypoglycemia; increased insulin sensitivity; abnormal lipid level Patched homolog 2 (PTCH2) Medulloblastoma; basal cell Normal viability and fertility; normal cell proliferation or carcinoma† differentiation in the cerebellum; abnormal dermal morphology in some males Granulocyte colony-stimulating factor (CSF3R) Kostmann neutropenia† Normal development and fertility; reduced numbers of peripheral neutrophils; fewer hematopoietic progenitors in bone marrow; impaired expansion and terminal differentiation of progenitors into granulocytes 5,10-methylenetetrahydrofolate reductase (MTHFR) Homocystinuria due to MTHFR Reduced survival rate but fertile; delayed development; deficiency† elevated plasma levels of homocysteine Transforming growth factor-␤ interacting factor (TGIF1) Holoprosencephaly-4† Normal growth, behavior and fertility Aacid phosphatase-2 (ACP2)* Acid phosphatase deficiency† Normal development and fertility; skeletal defects in mutants Ͼ6 months of age; a
Load more

Recommended publications
  • Epidemiology of Mucopolysaccharidoses Update
    diagnostics Review Epidemiology of Mucopolysaccharidoses Update Betul Celik 1,2 , Saori C. Tomatsu 2 , Shunji Tomatsu 1 and Shaukat A. Khan 1,* 1 Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE 19803, USA; [email protected] (B.C.); [email protected] (S.T.) 2 Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA; [email protected] * Correspondence: [email protected]; Tel.: +302-298-7335; Fax: +302-651-6888 Abstract: Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by a lysosomal enzyme deficiency or malfunction, which leads to the accumulation of glycosaminoglycans in tissues and organs. If not treated at an early stage, patients have various health problems, affecting their quality of life and life-span. Two therapeutic options for MPS are widely used in practice: enzyme replacement therapy and hematopoietic stem cell transplantation. However, early diagnosis of MPS is crucial, as treatment may be too late to reverse or ameliorate the disease progress. It has been noted that the prevalence of MPS and each subtype varies based on geographic regions and/or ethnic background. Each type of MPS is caused by a wide range of the mutational spectrum, mainly missense mutations. Some mutations were derived from the common founder effect. In the previous study, Khan et al. 2018 have reported the epidemiology of MPS from 22 countries and 16 regions. In this study, we aimed to update the prevalence of MPS across the world. We have collected and investigated 189 publications related to the prevalence of MPS via PubMed as of December 2020. In total, data from 33 countries and 23 regions were compiled and analyzed.
    [Show full text]
  • Transcriptome Analyses of Rhesus Monkey Pre-Implantation Embryos Reveal A
    Downloaded from genome.cshlp.org on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press Transcriptome analyses of rhesus monkey pre-implantation embryos reveal a reduced capacity for DNA double strand break (DSB) repair in primate oocytes and early embryos Xinyi Wang 1,3,4,5*, Denghui Liu 2,4*, Dajian He 1,3,4,5, Shengbao Suo 2,4, Xian Xia 2,4, Xiechao He1,3,6, Jing-Dong J. Han2#, Ping Zheng1,3,6# Running title: reduced DNA DSB repair in monkey early embryos Affiliations: 1 State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, China 2 Key Laboratory of Computational Biology, CAS Center for Excellence in Molecular Cell Science, Collaborative Innovation Center for Genetics and Developmental Biology, Chinese Academy of Sciences-Max Planck Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China 3 Yunnan Key Laboratory of Animal Reproduction, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, China 4 University of Chinese Academy of Sciences, Beijing, China 5 Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming, Yunnan 650204, China 6 Primate Research Center, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China * Xinyi Wang and Denghui Liu contributed equally to this work 1 Downloaded from genome.cshlp.org on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press # Correspondence: Jing-Dong J. Han, Email: [email protected]; Ping Zheng, Email: [email protected] Key words: rhesus monkey, pre-implantation embryo, DNA damage 2 Downloaded from genome.cshlp.org on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press ABSTRACT Pre-implantation embryogenesis encompasses several critical events including genome reprogramming, zygotic genome activation (ZGA) and cell fate commitment.
    [Show full text]
  • Purkinje Cell Migration Disorder By
    CEREBELLAR CORTICOGENESIS IN THE LYSOSOMAL ACID PHOSPHATASE (ACP2) MUTANT MICE: PURKINJE CELL MIGRATION DISORDER BY NILOUFAR ASHTARI A Thesis Submitted to the Faculty of Graduate Studies of The University of Manitoba in Partial Fulfilment of the Requirements for the Degree of MASTER OF SCIENCE Department of Human Anatomy and Cell Science University of Manitoba Winnipeg, Manitoba Copyright © 2017 by Niloufar Ashtari 1 Abstract In a mutant mouse called nax as the result of mutation in Lysosomal Acid phosphatase (Acp2), layers of the cerebellar cortex are impaired and monolayer Purkinje cells (Pcs) turn to multi-layered Pcs that ectopically invade the molecular layer. We investigated reelin-Dab1 signaling as an important pathway for Pcs migration and monolayer formation in cerebellum. ERK1/2 is a member of mitogen activated kinases family and suggested to be a downstream of reelin signaling. We hypothesize that the establishment of mono-layered Pcs rely on reelin through ERK1/2 pathway. Acp2 mutant mice were used for this study and molecular expression and distribution were assessed by immunohistochemistry, RT-PCR, western blotting, and cell culture. Results suggest that reelin may modulate the ERK1/2 expression, thus lower expression of reelin and higher phosphorylation of Dab1 leads to over expression of the ERK1/2 that causes the Pcs to over migrate and form multilayer in nax cerebellar cortex. i TABLE OF CONTENTS LISTOFABBREVIATIONS………………………………………………..…... IV LIST OF TABLES……………………………………...…………………...….. Vii LIST OF FIGURES…………………………………………………….………. Viii CHAPTER 1: INTRODUCTION…………………………………….………… 1 1.1 Cerebellum ……………………………………………………........………. 1 1.2 Development of Central Nervous System………………………………….. 2 1.3 Development of the cerebellum………………………………….................. 3 1.4 Specification of cerebellar germinal zones………………………………….
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Multivariate Meta-Analysis of Differential Principal Components Underlying Human Primed and Naive-Like Pluripotent States
    bioRxiv preprint doi: https://doi.org/10.1101/2020.10.20.347666; this version posted October 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license. October 20, 2020 To: bioRxiv Multivariate Meta-Analysis of Differential Principal Components underlying Human Primed and Naive-like Pluripotent States Kory R. Johnson1*, Barbara S. Mallon2, Yang C. Fann1, and Kevin G. Chen2*, 1Intramural IT and Bioinformatics Program, 2NIH Stem Cell Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA Keywords: human pluripotent stem cells; naive pluripotency, meta-analysis, principal component analysis, t-SNE, consensus clustering *Correspondence to: Dr. Kory R. Johnson ([email protected]) Dr. Kevin G. Chen ([email protected]) 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.10.20.347666; this version posted October 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license. ABSTRACT The ground or naive pluripotent state of human pluripotent stem cells (hPSCs), which was initially established in mouse embryonic stem cells (mESCs), is an emerging and tentative concept. To verify this important concept in hPSCs, we performed a multivariate meta-analysis of major hPSC datasets via the combined analytic powers of percentile normalization, principal component analysis (PCA), t-distributed stochastic neighbor embedding (t-SNE), and SC3 consensus clustering.
    [Show full text]
  • Congenital Disorders of Glycosylation from a Neurological Perspective
    brain sciences Review Congenital Disorders of Glycosylation from a Neurological Perspective Justyna Paprocka 1,* , Aleksandra Jezela-Stanek 2 , Anna Tylki-Szyma´nska 3 and Stephanie Grunewald 4 1 Department of Pediatric Neurology, Faculty of Medical Science in Katowice, Medical University of Silesia, 40-752 Katowice, Poland 2 Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland; [email protected] 3 Department of Pediatrics, Nutrition and Metabolic Diseases, The Children’s Memorial Health Institute, W 04-730 Warsaw, Poland; [email protected] 4 NIHR Biomedical Research Center (BRC), Metabolic Unit, Great Ormond Street Hospital and Institute of Child Health, University College London, London SE1 9RT, UK; [email protected] * Correspondence: [email protected]; Tel.: +48-606-415-888 Abstract: Most plasma proteins, cell membrane proteins and other proteins are glycoproteins with sugar chains attached to the polypeptide-glycans. Glycosylation is the main element of the post- translational transformation of most human proteins. Since glycosylation processes are necessary for many different biological processes, patients present a diverse spectrum of phenotypes and severity of symptoms. The most frequently observed neurological symptoms in congenital disorders of glycosylation (CDG) are: epilepsy, intellectual disability, myopathies, neuropathies and stroke-like episodes. Epilepsy is seen in many CDG subtypes and particularly present in the case of mutations
    [Show full text]
  • A Novel Frameshift Pathogenic Variant in ST3GAL5 Causing Salt
    www.nature.com/hgv DATA REPORT OPEN A novel frameshift pathogenic variant in ST3GAL5 causing salt and pepper developmental regression syndrome (SPDRS): A case report 1,2 3 2,3 4 fi4 4 Jamal Manoochehri , Seyed Alireza Dastgheib , Hossein Jafari Khamirani , Maryam Mollaie , Zahra Shari , Sina Zoghi✉ , Seyed Mohammad Bagher Tabei3,5, Sanaz Mohammadi2, Fatemeh Dehghanian2, Zahra Farbod2 and Mehdi Dianatpour3,6 © The Author(s) 2021 GM3 synthase deficiency is associated with salt and pepper developmental regression syndrome (SPDRS), a rare genetic disorder. Herein, we report the first Iranian patient with SPDRS. We detected a novel pathogenic variant of ST3GAL5 (NM_003896.4: c.1030_1031del, p.Ile344Cysfs*11). The proband had intellectual disability (ID), failure to thrive, cerebral atrophy, microcephaly, and atonic seizures. The main future challenge proceeding from the results of this study is the prenatal detection of the newly discovered variant; the next step would involve further studies to elucidate the phenotypic spectrum of SPDRS and detect new variants that could cause symptoms ranging from mild to severe. Human Genome Variation; https://doi.org/10.1038/s41439-021-00164-8 GM3 synthase is the first enzyme involved in the biosynthesis of a- occurrence of a set of complications and poor adherence by the and b-series gangliosides. Pathogenic variants in ST3GAL5 that family. Afterward, the dietary interventions were resumed. result in a complete lack of GM3 activity lead to the elimination of The first symptoms were recorded during the first 2 months of all of its downstream biosynthesis products. SPDRS, a rare life, primarily comprising irritability, poor feeding, and failure to neurological disorder caused by GM3 synthase deficiency, leads thrive.
    [Show full text]
  • Functional Significance of the Two ACOX1 Isoforms and Their
    Laboratory Investigation (2010) 90, 696–708 & 2010 USCAP, Inc All rights reserved 0023-6837/10 $32.00 Functional significance of the two ACOX1 isoforms and their crosstalks with PPARa and RXRa Aurore Vluggens1,2,3, Pierre Andreoletti1,2, Navin Viswakarma3, Yuzhi Jia3, Kojiro Matsumoto3, Wim Kulik4, Mushfiquddin Khan5, Jiansheng Huang3, Dongsheng Guo3, Sangtao Yu3, Joy Sarkar3, Inderjit Singh5, M Sambasiva Rao3, Ronald J Wanders4, Janardan K Reddy3 and Mustapha Cherkaoui-Malki1,2 Disruption of the peroxisomal acyl-CoA oxidase 1 (Acox1) gene in the mouse results in the development of severe microvesicular hepatic steatosis and sustained activation of peroxisome proliferator-activated receptor-a (PPARa). These mice manifest spontaneous massive peroxisome proliferation in regenerating hepatocytes and eventually develop hepatocellular carcinomas. Human ACOX1, the first and rate-limiting enzyme of the peroxisomal b-oxidation pathway, has two isoforms including ACOX1a and ACOX1b, transcribed from a single gene. As ACOX1a shows reduced activity toward palmitoyl-CoA as compared with ACOX1b, we used adenovirally driven ACOX1a and ACOX1b to investigate their efficacy in the reversal of hepatic phenotype in Acox1(À/À) mice. In this study, we show that human ACOX1b is markedly effective in reversing the ACOX1 null phenotype in the mouse. In addition, expression of human ACOX1b was found to restore the production of nervonic (24:1) acid and had a negative impact on the recruitment of coactivators to the PPARa-response unit, which suggests that nervonic acid might well be an endogenous PPARa antagonist, with nervonoyl-CoA probably being the active form of nervonic acid. In contrast, restoration of docosahexaenoic (22:6) acid level, a retinoid-X-receptor (RXRa) agonist, was dependent on the concomitant hepatic expression of both ACOX1a and ACOX1b isoforms.
    [Show full text]
  • Association of Gene Ontology Categories with Decay Rate for Hepg2 Experiments These Tables Show Details for All Gene Ontology Categories
    Supplementary Table 1: Association of Gene Ontology Categories with Decay Rate for HepG2 Experiments These tables show details for all Gene Ontology categories. Inferences for manual classification scheme shown at the bottom. Those categories used in Figure 1A are highlighted in bold. Standard Deviations are shown in parentheses. P-values less than 1E-20 are indicated with a "0". Rate r (hour^-1) Half-life < 2hr. Decay % GO Number Category Name Probe Sets Group Non-Group Distribution p-value In-Group Non-Group Representation p-value GO:0006350 transcription 1523 0.221 (0.009) 0.127 (0.002) FASTER 0 13.1 (0.4) 4.5 (0.1) OVER 0 GO:0006351 transcription, DNA-dependent 1498 0.220 (0.009) 0.127 (0.002) FASTER 0 13.0 (0.4) 4.5 (0.1) OVER 0 GO:0006355 regulation of transcription, DNA-dependent 1163 0.230 (0.011) 0.128 (0.002) FASTER 5.00E-21 14.2 (0.5) 4.6 (0.1) OVER 0 GO:0006366 transcription from Pol II promoter 845 0.225 (0.012) 0.130 (0.002) FASTER 1.88E-14 13.0 (0.5) 4.8 (0.1) OVER 0 GO:0006139 nucleobase, nucleoside, nucleotide and nucleic acid metabolism3004 0.173 (0.006) 0.127 (0.002) FASTER 1.28E-12 8.4 (0.2) 4.5 (0.1) OVER 0 GO:0006357 regulation of transcription from Pol II promoter 487 0.231 (0.016) 0.132 (0.002) FASTER 6.05E-10 13.5 (0.6) 4.9 (0.1) OVER 0 GO:0008283 cell proliferation 625 0.189 (0.014) 0.132 (0.002) FASTER 1.95E-05 10.1 (0.6) 5.0 (0.1) OVER 1.50E-20 GO:0006513 monoubiquitination 36 0.305 (0.049) 0.134 (0.002) FASTER 2.69E-04 25.4 (4.4) 5.1 (0.1) OVER 2.04E-06 GO:0007050 cell cycle arrest 57 0.311 (0.054) 0.133 (0.002)
    [Show full text]
  • Novel Alternative Splicing Variants of ACOX1 and Their Differential Expression Patterns in Goats
    Arch. Anim. Breed., 61, 59–70, 2018 https://doi.org/10.5194/aab-61-59-2018 Open Access © Author(s) 2018. This work is distributed under the Creative Commons Attribution 4.0 License. Archives Animal Breeding Novel alternative splicing variants of ACOX1 and their differential expression patterns in goats Xian-Feng Wu1,*, Yuan Liu1,*, Cheng-Fang Gao1, Xin-Zhu Chen1, Xiao-Pei Zhang1, and Wen-Yang Li1 1Institute of Animal Husbandry and Veterinary Medicine, Fujian Academy of Agricultural Sciences, Fuzhou, Fujian 350013, PR China *These authors contributed equally to this work. Correspondence: Wen-Yang Li ([email protected]) Received: 6 August 2017 – Revised: 29 October 2017 – Accepted: 14 November 2017 – Published: 24 January 2018 Abstract. As the first and rate-limiting enzyme of the peroxisomal β-oxidation pathway, acyl-coenzyme A ox- idase 1 (ACOX1), which is regulated by peroxisome proliferator-activated alfa (PPARα), is vital for fatty acid oxidation and deposition, especially in the lipid metabolism of very long-chain fatty acids. Alternative splicing events of ACOX1 have been detected in rodents, Nile tilapia, zebra fish and humans but not in goats. Herein, we identified a novel splice variant of the ACOX1 gene, which was designated as ACOX1-SV1, in addition to the complete transcript, ACOX1, in goats. The length of the ACOX1-SV1 coding sequence was 1983 bp, which presented a novel exon 2 variation owing to alternative 50-splice site selection in exon 2 and partial in- tron 1, compared to that in ACOX1. The protein sequence analysis indicated that ACOX1-SV1 was conserved across different species.
    [Show full text]
  • Bioinformatics Classification of Mutations in Patients with Mucopolysaccharidosis IIIA
    Metabolic Brain Disease (2019) 34:1577–1594 https://doi.org/10.1007/s11011-019-00465-6 ORIGINAL ARTICLE Bioinformatics classification of mutations in patients with Mucopolysaccharidosis IIIA Himani Tanwar1 & D. Thirumal Kumar1 & C. George Priya Doss1 & Hatem Zayed2 Received: 30 April 2019 /Accepted: 8 July 2019 /Published online: 5 August 2019 # The Author(s) 2019 Abstract Mucopolysaccharidosis (MPS) IIIA, also known as Sanfilippo syndrome type A, is a severe, progressive disease that affects the central nervous system (CNS). MPS IIIA is inherited in an autosomal recessive manner and is caused by a deficiency in the lysosomal enzyme sulfamidase, which is required for the degradation of heparan sulfate. The sulfamidase is produced by the N- sulphoglucosamine sulphohydrolase (SGSH) gene. In MPS IIIA patients, the excess of lysosomal storage of heparan sulfate often leads to mental retardation, hyperactive behavior, and connective tissue impairments, which occur due to various known missense mutations in the SGSH, leading to protein dysfunction. In this study, we focused on three mutations (R74C, S66W, and R245H) based on in silico pathogenic, conservation, and stability prediction tool studies. The three mutations were further subjected to molecular dynamic simulation (MDS) analysis using GROMACS simulation software to observe the structural changes they induced, and all the mutants exhibited maximum deviation patterns compared with the native protein. Conformational changes were observed in the mutants based on various geometrical parameters, such as conformational stability, fluctuation, and compactness, followed by hydrogen bonding, physicochemical properties, principal component analysis (PCA), and salt bridge analyses, which further validated the underlying cause of the protein instability. Additionally, secondary structure and surrounding amino acid analyses further confirmed the above results indicating the loss of protein function in the mutants compared with the native protein.
    [Show full text]
  • Review of the Molecular Genetics of Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, and Targeted Therapeutics
    cancers Review Review of the Molecular Genetics of Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, and Targeted Therapeutics James M. Kilgour , Justin L. Jia and Kavita Y. Sarin * Department of Dermatology, Stanford University School of Medcine, Stanford, CA 94305, USA; [email protected] (J.M.K.); [email protected] (J.L.J.) * Correspondence: [email protected] Simple Summary: Basal cell carcinoma is the most common human cancer worldwide. The molec- ular basis of BCC involves an interplay of inherited genetic susceptibility and somatic mutations, commonly induced by exposure to UV radiation. In this review, we outline the currently known germline and somatic mutations implicated in the pathogenesis of BCC with particular attention paid toward affected molecular pathways. We also discuss polymorphisms and associated phenotypic traits in addition to active areas of BCC research. We finally provide a brief overview of existing non-surgical treatments and emerging targeted therapeutics for BCC such as Hedgehog pathway inhibitors, immune modulators, and histone deacetylase inhibitors. Abstract: Basal cell carcinoma (BCC) is a significant public health concern, with more than 3 million cases occurring each year in the United States, and with an increasing incidence. The molecular basis of BCC is complex, involving an interplay of inherited genetic susceptibility, including single Citation: Kilgour, J.M.; Jia, J.L.; Sarin, nucleotide polymorphisms and genetic syndromes, and sporadic somatic mutations, often induced K.Y. Review of the Molecular Genetics of Basal Cell Carcinoma; by carcinogenic exposure to UV radiation. This review outlines the currently known germline and Inherited Susceptibility, Somatic somatic mutations implicated in the pathogenesis of BCC, including the key molecular pathways Mutations, and Targeted affected by these mutations, which drive oncogenesis.
    [Show full text]